Association between GvHD and nivolumab in the FDA adverse event reporting system

被引：7
|
作者：
Oshima, Y. [1 ]
Tanimoto, T. [2 ]
Yuji, K. [1 ]
Tojo, A. [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Tokyo, Japan
[2] Tokiwa Fdn, Jyoban Hosp, Fukushima, Japan
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 10期
关键词：
HOST-DISEASE LETHALITY; LYMPHOMA; BLOCKADE; TRANSPLANTATION; EFFICACY;
D O I：
10.1038/bmt.2017.158
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1463 / 1464
页数：2
相关论文
共 50 条
  • [11] Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database
    Hailong Li
    Miao Zhang
    Xuefeng Jiao
    Yu Zhu
    Yan Liu
    Linan Zeng
    Huiqing Wang
    Lei Zhang
    Wei Zhang
    Lingli Zhang
    [J]. Scientific Reports, 13
  • [12] Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database
    Li, Hailong
    Zhang, Miao
    Jiao, Xuefeng
    Zhu, Yu
    Liu, Yan
    Zeng, Linan
    Wang, Huiqing
    Zhang, Lei
    Zhang, Wei
    Zhang, Lingli
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [13] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [14] Exploring the Rising Incidence of Myocarditis and Other Cardiovascular Adverse Events of Nivolumab and Ipilimumab: Analysis of FDA Adverse Event Reporting System Database
    Khanal, Resha
    Oli, Sharad
    Rajak, Kripa
    Halder, Anupam
    Hufdhi, Raied
    Bhandari, Binita
    Oli, Shital
    Alraies, M. Chadi C.
    [J]. CIRCULATION, 2023, 148
  • [15] Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system
    Zhou, Huaqiang
    Liu, Jiaqing
    Zhang, Yaxiong
    Zhang, Li
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 599 - 601
  • [16] Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system
    Huaqiang Zhou
    Jiaqing Liu
    Yaxiong Zhang
    Li Zhang
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 599 - 601
  • [17] Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
    Katsuhiro Ohyama
    Junichiro Shindo
    Tomohiro Takahashi
    Hironori Takeuchi
    Yusuke Hori
    [J]. Scientific Reports, 12
  • [18] Pharmacovigilance study of the association between peripheral neuropathy and antibody-drug conjugates using the FDA adverse event reporting system
    Chen, Yuheng
    Ren, Xiayang
    Dai, Yuanyuan
    Wang, Yanfeng
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [19] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Iyer, Geetha
    Marimuthu, Sathiya Priya
    Segal, Jodi B.
    Singh, Sonal
    [J]. DRUG SAFETY, 2017, 40 (09) : 799 - 808
  • [20] Data Mining of the Public Version of the FDA Adverse Event Reporting System
    Sakaeda, Toshiyuki
    Tamon, Akiko
    Kadoyama, Kaori
    Okuno, Yasushi
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (07): : 796 - 803
12345